NewzNEW YORK (AP) — NEW YORK (AP) — Oramed Pharmaceuticals Inc. (ORMP) on Monday reported earnings of $78.2 million in its second quarter. The New York-based company said it had net income of $1.84 per share.
Losses, adjusted for non-recurring gains, were 9 cents per share. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ORMP at https://www.zacks.com/ap/ORMP Source
(SCYX) on Monday reported profit of $7.4 million in its second quarter. The Jersey City, New Jersey-based company said it had net income of 63 cents per share. Losses, adjusted for non-recurring gains, came to 32 cents per share.
The pharmaceutical company posted revenue of $235,000 in the period. Access a Zacks stock report on SCYX at https://www.zacks.com/ap/SCYX Source (AP) — Insight Molecular Diagnostics Inc.
(IMDX) on Monday reported a loss of $11.3 million in its second quarter. The Nashville, Tennessee-based company said it had a loss of 31 cents per share. Losses, adjusted for non-recurring costs, came to 23 cents per share.
The cancer diagnostic test developer posted revenue of $239,000 in the period. Access a Zacks stock report on IMDX at https://www.zacks.com/ap/IMDX Source
Summary from source